Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) is now available.
Shanghai HeartCare Medical Technology Corporation Limited has announced that its board of directors will meet on March 27, 2025, to consider and approve the annual results for the year ended December 31, 2024. The meeting will also address the potential recommendation for a final dividend payment. This announcement indicates the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its financial outlook and investor relations.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing advanced medical technology solutions.
YTD Price Performance: 46.70%
Average Trading Volume: 52,763
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.25B
Find detailed analytics on 6609 stock on TipRanks’ Stock Analysis page.